Dr. Matthew W. Schelke, MD

Dr. Schelke practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Schelke's NPI, 1043743933, was assigned on April 6, 2017. Dr. Schelke graduated from Weill Cornell Medicine in 2017. Dr. Schelke holds New York license 297887.

Dr. Schelke's primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Schelke's primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. Dr. Schelke is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Schelke to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schelke practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Schelke's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Schelke is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Schelke is licensed in New York.

Dmand AI lists carpal tunnel syndrome, cerebrovascular disease, fibromyalgia and chronic pain, hereditary polyneuropathy, lower back pain, migraine and chronic headache, muscle disease and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Schelke treats.

CMS data shows 349 Medicare services from Dr. Schelke across 6 procedure codes in 2024, for 146 Medicare patients. Medicare paid $39,141 for them. Every service was in an office.

CMS counts 146 Medicare patients who saw Dr. Schelke in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schelke's median patient age at 59, with 63% women.

In 2024, Dr. Schelke wrote 808 Medicare Part D claims for 176 patients. 77% of them were for generic drugs. CMS names the drug for 613 of them, across 25 drugs with 11 or more claims each, at $584,077 in total drug cost. In 2023, CMS named 321 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Schelke for performance year 2024, reported through an alternative payment model (APM). Dr. Schelke accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schelke as offering telehealth.

Dmand AI links 6 papers to Dr. Schelke, published from 2015 to 2022. The most frequent topics are Alzheimer Disease, Cognition and Risk Reduction Behavior. Dr. Schelke's most frequent co-authors are Richard S. Isaacson, MD, Gloria Chia-Yi Chiang, MD and Matthew E. Fink, MD.

CMS Open Payments shows 40 general payments to Dr. Schelke from 7 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $385.

Dr. Schelke graduated from Weill Cornell Medicine in 2017. Dr. Schelke is a member of AAN.

Dr. Schelke is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.